Evidence map›Paper›PMID 27053563›Full record

ArticleComparative medicine2016

Comparison of 3 Topical Treatments against Ulcerative Dermatitis in Mice with a C57BL/6 Background.

Carmen R Michaud, Jing Qin, William R Elkins, Alfonso S Gozalo

Open access · greenAbstract readComparative Study
In one paragraph

Article in Comparative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Pharmacokinetics of Single-bolus Subcutaneous Cefovecin in C57BL/6 Mice.Journal of the American Association for Laboratory Animal Science : JAALAS · 2017
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluation of Treatment Options for Ulcerative Dermatitis in the P Rat.Journal of the American Association for Laboratory Animal Science : JAALAS · 2021
    Article
  7. Antimicrobial Stewardship in Laboratory Animal Facilities.Journal of the American Association for Laboratory Animal Science : JAALAS · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carmen R MichaudComparative Medicine Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Jing QinBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
William R ElkinsComparative Medicine Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Alfonso S GozaloComparative Medicine Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA. gozaloa@niaid.nih.gov.
National Institute of Allergy and Infectious Diseases · US

Funding

Comparative Medicine Infectious Diseases- BethesdaZIGAI001047 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ELKINS, WILLIAM · 2009 to 2025
$535.6M
Intramural NIH HHS
6 · The paper itself

Abstract

Ulcerative dermatitis (UD) is a common condition in C57BL/6 mice and strains with this background. The etiology of UD is unclear but appears to have a genetic component associated with the C57BL/6 strain and has been reported as secondary to a variety of conditions. Treatment is unrewarding, resulting in euthanasia in many cases. In the present study we compared 3 topical treatments against spontaneous UD in mice with a C57BL/6 background. In total, 301 mice of both sexes were included in this study, and the tested treatments comprised bacitracin-neomycin sulfate-polymixin B sulfate ointment twice daily, 10% povidone-iodine ointment plus 1% silver sulfadiazine cream once daily, and 0.005% sodium hypochlorite once daily. Lesion healing was defined as complete skin reepithelialization with or without hair regrowth. Sex, age, lesion location, and type and length of treatment were analyzed by using univariate and multivariate logistic regression. Of the 79 mice treated with triple-antibiotic ointment, 27 (34%) healed, compared with 43 of the 125 (34%) treated with povidone-iodine and sulfadiazine and 69 of the 97 (71%) treated with hypochlorite. Lesion size and treatment with 0.005% sodium hypochlorite were the only significant predictors of healing; all other variables were not statistically significant in multivariate analysis. We conclude that 0.005% sodium hypochlorite is an effective topical treatment alternative for UD in C57BL/6 mice and strains on this background, and a favorable prognosis depends on the early identification and treatment of those lesions.

Indexed as

Mice, Inbred C57BLAdministration, TopicalAnimal DiseasesAnimalsBacitracinDermatitisDrug CombinationsFemaleLogistic ModelsMaleMiceNeomycinPolymyxin BPovidone-IodineRodent DiseasesSilver SulfadiazineBacitracinbacitracin zinc, neomycin sulfate, polymyxin B, drug combinationDrug CombinationsNeomycinPolymyxin BPovidone-IodineSilver SulfadiazineSodium Hypochlorite

Identifiers

PMID27053563
PMCPMC4825958
OpenAlexW2338132796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.